Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EBIT Growth

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) 0.9721.2241.65-15.6018.78

What is the latest EBIT Growth ratio of MANKIND PHARMA ?

The latest EBIT Growth ratio of MANKIND PHARMA is 0.97 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar20260.97
Mar202521.22
Mar202441.65
Mar2023-15.60
Mar202218.78

How is EBIT Growth of MANKIND PHARMA Trending?

Years EBIT Growth % Change
Mar2026 0.97
-95.43
Mar2025 21.22
-49.05
Mar2024 41.65
Positive
Mar2023 -15.6
Negative
Mar2022 18.78 -

Other Financial Ratios of MANKIND PHARMA


Compare EBIT Growth ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹93,957.5 Cr -5.2% 1.2% -4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.1% -5% 5.4% Stock Analytics
DIVIS LABORATORIES ₹244,762.0 Cr -1.7% 0.2% 39.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,448.0 Cr -2.5% -5.5% 30.2% Stock Analytics
CIPLA ₹107,043.0 Cr 0.9% -2.6% -14.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,820.0 Cr 0.1% 7.6% -3.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-5.2%

1.2%

-4.2%

SENSEX

3.1%

1%

-9.1%


You may also like the below Video Courses